QIAGEN NV's ticker is QGENXXXX and the CUSIP is N72482107. A total of 160 filers reported holding QIAGEN NV in Q2 2014. The put-call ratio across all filers is 0.05 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $4,512,000 | -27.0% | 161,029 | -28.5% | 0.01% | -31.6% |
Q3 2016 | $6,182,000 | +6.2% | 225,293 | -15.6% | 0.02% | +5.6% |
Q2 2016 | $5,819,000 | -10.7% | 266,790 | -8.5% | 0.02% | -14.3% |
Q1 2016 | $6,516,000 | -30.2% | 291,669 | -13.7% | 0.02% | -22.2% |
Q4 2015 | $9,341,000 | -2.9% | 337,826 | -9.4% | 0.03% | -10.0% |
Q3 2015 | $9,624,000 | -23.5% | 373,031 | -26.5% | 0.03% | -3.2% |
Q2 2015 | $12,586,000 | +12.4% | 507,720 | +14.2% | 0.03% | +14.8% |
Q1 2015 | $11,202,000 | +8.6% | 444,554 | +1.1% | 0.03% | +3.8% |
Q4 2014 | $10,319,000 | +23.2% | 439,841 | +19.6% | 0.03% | +30.0% |
Q3 2014 | $8,373,000 | +2.0% | 367,742 | +9.6% | 0.02% | -4.8% |
Q2 2014 | $8,207,000 | -12.0% | 335,668 | -24.5% | 0.02% | -22.2% |
Q1 2014 | $9,328,000 | +33.5% | 444,459 | +51.5% | 0.03% | +28.6% |
Q4 2013 | $6,986,000 | +8.3% | 293,435 | -2.7% | 0.02% | -8.7% |
Q3 2013 | $6,452,000 | +62.6% | 301,464 | +51.2% | 0.02% | +35.3% |
Q2 2013 | $3,969,000 | – | 199,347 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tikvah Management LLC | 369,425 | $9,032,000 | 6.36% |
Hardman Johnston Global Advisors LLC | 4,586,856 | $112,149,000 | 5.99% |
Eclectica Asset Management LLP | 90,950 | $2,223,000 | 2.21% |
Douglas C. Lane & Associates, Inc. | 1,970,371 | $48,176,000 | 1.46% |
HARDING LOEVNER LP | 6,978,369 | $170,621,000 | 1.27% |
CRAMER ROSENTHAL MCGLYNN LLC | 3,911,835 | $95,644,000 | 0.77% |
PLATINUM INVESTMENT MANAGEMENT LTD | 1,781,076 | $43,547,000 | 0.76% |
GLG Partners LP | 1,220,148 | $29,833,000 | 0.71% |
Sivik Global Healthcare LLC | 49,451 | $1,209,000 | 0.61% |
PRIMECAP MANAGEMENT CO/CA/ | 22,087,404 | $540,037,000 | 0.59% |